REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Plant Material Or Plant Extract Of Undetermined Constitution As Active Ingredient (e.g., Herbal Remedy, Herbal Extract, Powder, Oil, Etc.) > Containing Or Obtained From Ginkgo (e.g., Ginkgo Biloba, Maidenhair, Etc.) Containing Or Obtained From Ginkgo (e.g., Ginkgo Biloba, Maidenhair, Etc.)Containing Or Obtained From Ginkgo (e.g., Ginkgo Biloba, Maidenhair, Etc.) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070020349 - Combinations of vasoactive agents, their use in the pharmaceutical and cosmetic field, and formulations containing them This invention relates to combinations of vasoactive substances which act at venous or arterial level with phosphodiesterase inhibitors including phosphodiesterase V, in particular: visnadin or esculoside; at least one compound selected from icarin or derivatives thereof or extracts containing it, Gingko biloba dimeric flavones either in the free form or ... 01/18/07 - 20070014880 - Method for preparing ginkgo extracts having a reduced content of nonpolar plant ingredients and nonpolar impurities due to enviromental influences The invention further relates to an extract (liquid extract or spissum extract as well as dry extract) from ginkgo biloba having a reduced content of nonpolar plant ingredients and nonpolar impurities due to environmental influences compared to the initial extract, which is obtainable by the method of the present invention. ... 12/28/06 - 20060292249 - Oral compositions for the treatment of cellulite The present invention relates to oral pharmaceutical and cosmetic compositions for the treatment of cellulite containing Vitis vinifera extracts, Centella asiatica triterpenes and dimeric Ginkgo biloba flavonoids, in the free form or complexed with phospholipids. ... 11/09/06 - 20060251746 - Method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones The present invention relates to an improved multi-step method for preparing an extract from ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones, wherein the depletion is carried out by filtration over an adsorber resin and/or an ion exchanger and the substances to be removed are retained on ... 11/09/06 - 20060251745 - Method for preparing a ginkgo extract having a reduced content of 4'-o-methyl pyridoxine and/or biflavones The invention further relates to extracts from Ginkgo biloba having a reduced content of 4′-O-methyl pyridoxine and/or biflavones compared to the original extract, which is obtainable by the method according to the present invention, as well as to their use. ... 11/09/06 - 20060251744 - Method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons The present invention relates to an improved multi-step method for preparing an extract from Ginkgo biloba having a reduced content of polycyclic aromatic hydrocarbons. The invention further relates to an extract from Ginkgo biloba having a reduced content of polycyclic aromatic hydrocarbons which is obtainable by the method according to ... 09/07/06 - 20060198910 - Method for processing vegetable raw materials The inventive method for processing vegetable raw materials consisting in organic solvent-extracting said materials, isolating it by retention which is associated with cooling and wax filtration, separating free oxides from the thus obtained solution of extractive substances by alkali solution action, dividing the obtained neutralised solution into a neutral substance ... 08/17/06 - 20060182821 - Use of a plant extract The present invention is directed to the use of the extract of Ginkgo biloba leaves or isolated Ginkgolide B (GKB), a component of the extract of Ginkgo biloba leaves in a method for decreasing the expression of peripheral-type benzodiazepine_receptor (PBR) in cells of a patient in need thereof. Further, the ... 06/15/06 - 20060127508 - Preparation for the relief of disease A composition including (a) a Platelet Activating Factor (PAF) Inhibitor and (b) an antioxidant which interferes with the arachidonic acid cascade and also has antioxidant activity. The composition is useful for the treatment or the relief of inflammatory diseases, thrombosis, cardiac problems, and/or conditions caused by platelet induced blood clotting. ... 06/08/06 - 20060121135 - Use of extracts of ginkgo biloba for preparing a medicament intended to treat sarcopenia A method of treating sarcopenia in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of an extract of Ginkgo biloba comprising from 5.5 to 8% in totoal of ginkgolides A, B, C and J, from 40 to 60% of flavoneglycosides and from 5 to 7% of ... 05/11/06 - 20060099278 - Formulations containing melatonin, ginkgo biloba, and biotin The present invention relates to a composition which comprises as active ingredients a combination of melatonin, ginkgo biloba and biotin. The composition is particularly suitable for producing formulations for topical application in the hair. ... 03/02/06 - 20060045926 - Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin A composition for application to the skin can stimulate the in vivo synthesis of collagen and proteoglycans and improve the appearance of the skin, increasing its elasticity and fullness. In general, a composition according to the present invention comprises: (1) an antioxidant compound in a quantity sufficient to enhance collagen ... 01/12/06 - 20060008542 - Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease Improved pharmaceutical compositions which include Ginkgo biloba and Picrorrhiza kurroa or extracts thereof, having a reduced amount of (or which do not include) components of natural Ginkgo biloba and natural Picrorrhiza kurroa which have effects which are detrimental to the effect or the pharmaceutical. ... 12/22/05 - 20050281899 - Ginkgolides for inhibition of membrane expression of benzodiazepine receptors Ginkgolides may be used to inhibit the membrane expression of a benzodiazepine receptor in a patient and in treatments to combat excess glucocorticoid production. ... 09/15/05 - 20050202107 - Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass The invention relates to the use of Ginkgo biloba extracts and, in particular, Ginkgo biloba extracts comprising between 20 and 30% flavoneglycosides, between 2.5 and 4.5% in total of ginkgolides A, B, C and J, between 2 and 4% bilobalide, less than 10% proanthocyanidins and less than 10 ppm alkylphenol-type ... 07/28/05 - 20050163873 - Methods and formulations for treating glaucoma Embodiments of the invention are directed toward neuroprotective formulations that may prevent the progression of glaucoma by strengthening the resistance of nerve cells to damage. Some embodiments of the invention are directed toward neuroprotective formulations that may limit and prevent glaucomatous damage by blocking the mechanisms that lead to retinal ... 06/23/05 - 20050136136 - Method for isolating terpene trilactones (ginkgolides, bilobadide) from leaves and pharmaceutical powders of ginkgo biloba A method of isolating terpene trilactones from Ginkgo biloba plant material or extract comprising the steps of suspending the plant material or extract in either water or an aqueous solution of an oxidation reagent; extracting the terpene trilactones using an acceptable extraction agent; separating the organic layer from the aqueous ... 06/02/05 - 20050118286 - Compositions and methods for treatment of nervous system disorders The present invention contemplates compositions and methods to treat patients having a nervous system disorder with a formulation comprising an anticonvulsant and a neuroactive modulator. Also described is a method to predict the probability of a significant recovery when a treating an individual patient having a nervous system disorder with ... ### FreshPatents.com Support |